Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        DBV-135 by DBV Technologies for Eosinophilic Esophagitis: Likelihood of Approval
DBV-135 is under clinical development by DBV Technologies and currently in Phase II for Eosinophilic Esophagitis. According to GlobalData, Phase...
                                                Data Insights
                                                
                                        DBV-135 by DBV Technologies for Milk Allergy: Likelihood of Approval
DBV-135 is under clinical development by DBV Technologies and currently in Phase II for Milk Allergy. According to GlobalData, Phase...
